中国中医科学院西苑医院血管外科
纸质出版:2012
移动端阅览
[1]马鲁波,于春利,刘剑刚,庄百溪,史大卓.气血并治方联合西药治疗下肢动脉硬化闭塞症股动脉支架植入术后60例远期疗效观察[J].中医杂志,2012,53(11):939-941+944.
MA Lubo, YU Chunli, LIU Jiangang, et al. Long-Term Effect of Qi-Blood Regulation Formula Combined with West ern Medicine on 60 Patients with Arteriosclerosis Obliterans after Femoral Artery Stenting[J]. Journal of Traditional Chinese Medicine2012, 53(11): 939-941.
[1]马鲁波,于春利,刘剑刚,庄百溪,史大卓.气血并治方联合西药治疗下肢动脉硬化闭塞症股动脉支架植入术后60例远期疗效观察[J].中医杂志,2012,53(11):939-941+944. DOI: 10.13288/j.11-2166/r.2012.11.029.
MA Lubo, YU Chunli, LIU Jiangang, et al. Long-Term Effect of Qi-Blood Regulation Formula Combined with West ern Medicine on 60 Patients with Arteriosclerosis Obliterans after Femoral Artery Stenting[J]. Journal of Traditional Chinese Medicine2012, 53(11): 939-941. DOI: 10.13288/j.11-2166/r.2012.11.029.
目的观察气血并治方对下肢动脉硬化闭塞症(ASO)股动脉支架植入后的临床疗效。方法选择ASO股动脉支架植入患者120例(142条患肢)
随机分为中药组60例(72条患肢)
对照组60例(70条患肢)。所有患者均予长期口服抗血小板药物治疗
中药组加用气血并治方口服。观察两组患者术后6、12、24个月间歇性跛行、静息痛、截肢情况、踝/肱指数(ABI)、血管通畅率等。结果两组患者术后6、12、24个月与本组术前比较
间歇性跛行、静息痛均明显改善(P<0.01)。术后6、12个月中药组与对照组比较间歇性跛行、静息痛症状差异无统计学意义(P>0.05)
术后24个月间歇性跛行明显降低(P<0.05)。对照组与中药组患者术后6个月血管通畅率分别为83%(45/54例)、88%(46/52例);12个月分别为69%(37/54例)、81%(42/52例);24个月分别为54%(29/54例)、77%(40/52例)。两组术后6个月和12个月血管通畅率差异无统计学意义(P>0.05);中药组术后24个月血管通畅率显著高于对照组(P<0.05)。两组患者术后6、12、24个月ABI与本组术前比较差异有统计学意义(P<0.01)。术后6个月中药组ABI与对照组比较差异无统计学意义(P>0.05)
术后12个月、24个月中药组ABI较对照组显著增加(P<0.05)。结论气血并治方可明显提高ASO患者股动脉支架术后血管通畅率
改善肢体缺血症状。
Objective To observe the effect of Qi-Blood Regulation Formula on arteriosclerosis obliterans(ASO) after the femoral artery stenting.Methods Totally 120 ASO patients(142 limbs) after femoral artery stenting were rand omized into Chinese medication group(60 cases
72 diseased limbs) and control gr oup(60 cases
70 diseased limbs).Both groups were given antiplatelet drugs and Qi-Blood Regulation Formula was added in the Chinese medication group.Intermittent clau dication
rest pain
amputation rate
ankle branch index(ABI) and vascular patency rate were observed.Results Comparing in group
intermittent clau dication and rest pain relieved significantly in both groups 6
12 or 24 months later(P<0.01).There was no significant difference between groups in the r elief of intermittent claudication and rest pain 6 or 12 months later(P>0.05). Intermittent claudication significantly relieved in the Chinese medication group as c ompared with the control group 24 months later(P<0.05).The target artery patency rate of the Chinese medication group and the control group was 83%(45/54) and 88%(46/52) respectively 6 months later
69%(37/54) and 81%(42/52) respectively 12 months later
and 5 4%(29/54) and 77%(40/52) respectively 24 months later.There was no significan t difference between groups in the target artery patency rate 6 or 12 months lat er(P>0.05).The target artery patency rate in the Chinese medication group was significantly higher than that in the control group 24 months later(P<0.05).Co mparing in group
ABI was significantly improved in both groups 6
12 or 24 mont hs later(P<0.01).There was no significant difference between groups in AB I 6 m onths later(P>0.05).The ABI in the Chinese medication group was significa ntly increased than that in the control group 12 or 24 months later(P<0.05).Conclusion Qi-Blood Regulation Formula is effective in improving the target artery pat ency rate after the femoral artery stenting and relieving the symptoms of lower l imb ischemia.
0
浏览量
177
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号